| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/12/2006 | CA2572685A1 Substituted 1-propiolylpiperazines compounds |
| 01/12/2006 | CA2572597A1 Hydroxyamate-containing materials for the inhibition of matrix metalloproteinases |
| 01/12/2006 | CA2572540A1 Arylalkylamine vanadium (v) salts for the treatment and/or prevention of diabetes mellitus |
| 01/12/2006 | CA2572519A1 Nucleic acids for the treatment of hmgb1-related pathologies |
| 01/12/2006 | CA2572491A1 Oral dosage form safeguarded against abuse |
| 01/12/2006 | CA2572439A1 Immunostimulatory sirna molecules and uses therefor |
| 01/12/2006 | CA2572363A1 Biomaterial |
| 01/12/2006 | CA2572352A1 Oral dosage form safeguarded against abuse containing (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol |
| 01/12/2006 | CA2572350A1 Tetrahydroquinolines |
| 01/12/2006 | CA2572316A1 Imidazolo-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572314A1 Pyrrolo[2,3-d]pyrimidines that modulate ack1 and lck activity |
| 01/12/2006 | CA2572310A1 Sphingolipid-derived pharmaceutical compositions |
| 01/12/2006 | CA2572223A1 Angiogenesis inhibitors |
| 01/12/2006 | CA2572167A1 Quinolone-containing medicinal composition |
| 01/12/2006 | CA2572163A1 Pyrazole derivatives |
| 01/12/2006 | CA2572126A1 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 01/12/2006 | CA2572125A1 Substituted tetrahydroisochinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drags |
| 01/12/2006 | CA2572119A1 Combination therapies utilizing benzamide inhibitors of the p2x7 receptor |
| 01/12/2006 | CA2572118A1 Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid |
| 01/12/2006 | CA2572084A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572083A1 Fused pyrimidine derivatives and compositions thereof as cxcr3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 01/12/2006 | CA2572075A1 Hetero isonipecotic modulators of vanilloid vr1 receptor |
| 01/12/2006 | CA2572058A1 Azaindoles useful as inhibitors of protein kinases |
| 01/12/2006 | CA2572054A1 Crystalline form iv of linezolid |
| 01/12/2006 | CA2572031A1 Fat combustion accelerator |
| 01/12/2006 | CA2571857A1 Furanopyrimidines |
| 01/12/2006 | CA2571822A1 Preventive or therapeutic agent for vascular intimal proliferative disease |
| 01/12/2006 | CA2571738A1 Thiazolinone unsubstituted quinolines |
| 01/12/2006 | CA2571732A1 Quinoline thiazolinones with cdk1 antiproliferative activity |
| 01/12/2006 | CA2571683A1 Methods and reagents for the treatment of metabolic disorders |
| 01/12/2006 | CA2571680A1 Fused heterocyclic kinase inhibitors |
| 01/12/2006 | CA2571588A1 Pyrazolopyridine derivatives |
| 01/12/2006 | CA2571519A1 Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant |
| 01/12/2006 | CA2571440A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 01/12/2006 | CA2571124A1 Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
| 01/12/2006 | CA2570908A1 Use of trisubstituted benzopyranones |
| 01/12/2006 | CA2570533A1 Substituted hydroxyacetophenon derivatives |
| 01/12/2006 | CA2570319A1 Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases |
| 01/12/2006 | CA2570318A1 Biaryl derivatives |
| 01/12/2006 | CA2570268A1 Use of acetyl l-carnitine for the preparation of a medicine for the treatment of neuropathic pain in diabetic patients |
| 01/12/2006 | CA2570245A1 Compositions and methods for treating pathological infections |
| 01/12/2006 | CA2570224A1 Sulphated depolymerised derivatives of exopolysaccharides (eps), preparation and uses thereof |
| 01/12/2006 | CA2570213A1 Alpha-helical mimetics |
| 01/12/2006 | CA2570199A1 Use of highly sulfated polysaccharide derivatives of low molar mass for modulating angiogenesis |
| 01/12/2006 | CA2570185A1 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| 01/12/2006 | CA2570169A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | CA2570048A1 Combination therapies employing platelet aggregation drugs |
| 01/12/2006 | CA2569915A1 D-xylopyranosyl-substituted phenyls, medicaments containing said compounds, the use thereof, and methods for producing the same |
| 01/12/2006 | CA2569856A1 Prebiotic preparation |
| 01/12/2006 | CA2569827A1 Quinazolinedione derivatives as parp inhibitors |
| 01/12/2006 | CA2569826A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | CA2569824A1 Phthalazine derivatives as parp inhibitors |
| 01/12/2006 | CA2569727A1 Compounds |
| 01/12/2006 | CA2569716A1 Hydantoin derivatives for the treatment of obstructive airway diseases |
| 01/12/2006 | CA2569681A1 Method for increasing the susceptibility of peptide deformylase inhibitors by using efflux pump inhibitors |
| 01/12/2006 | CA2569589A1 Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/12/2006 | CA2569519A1 Topical formulations for treating allergic diseases |
| 01/12/2006 | CA2568835A1 Quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | CA2568834A1 Medicaments for inhalation comprising steroids and an anticholinergic |
| 01/12/2006 | CA2568262A1 Hydroalcoholic depigmentation gel comprising mequinol and adapalene |
| 01/12/2006 | CA2567744A1 Substituted indazoles, compositions containing same, preparation and use |
| 01/12/2006 | CA2566648A1 Guanylhydrazone salts, compositions, processes of making and methods of using |
| 01/12/2006 | CA2565683A1 Substituted azepine derivatives as serotonin receptor modulators |
| 01/12/2006 | CA2564996A1 3-aryl-5,6-disubstituted pyridazines |
| 01/12/2006 | CA2547934A1 Methods of using gamma cyclodextrin to control blood glucose and insulin secretion |
| 01/12/2006 | CA2503007A1 Method and product |
| 01/11/2006 | EP1614689A1 Benzoxepino-11-piperidylidene compounds and process for production thereof |
| 01/11/2006 | EP1614688A1 Phenylazole compound, production process, and antioxidant drug |
| 01/11/2006 | EP1614687A1 Process for the preparation of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one derivatives and their application in the synthesis of ivabradine and its pharmaceutically acceptable salts |
| 01/11/2006 | EP1614684A1 Diamine derivative, production process, and antioxidizing drug |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614681A1 Fexofenadine polymorphs and process for the preparation thereof |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614675A2 Amino acids with affinity for the alpha-2-delta protein |
| 01/11/2006 | EP1614432A2 Method for treating amyloidosis |
| 01/11/2006 | EP1614431A2 Compositions for treatment of disorders of the oesophagus |
| 01/11/2006 | EP1614429A1 Lklf/klf2 gene expression promoter |
| 01/11/2006 | EP1614428A1 Drug for preventing or treating angiogenic eye diseases |
| 01/11/2006 | EP1614422A2 Ibandronate for the promotion of osseointegration of endoprostheses |
| 01/11/2006 | EP1614421A2 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/11/2006 | EP1614420A2 Treatment of hypertension, angina and other disorders using (-) amlodipine |
| 01/11/2006 | EP1614419A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 01/11/2006 | EP1614418A1 use of(-)(3-trihalomethylphenoxy) (4-halophenyl)acetic acid derivatives for treatment of hyperuricaemia |
| 01/11/2006 | EP1614417A1 Solid preparation for oral use |
| 01/11/2006 | EP1614416A2 Method for treating amyloidosis |
| 01/11/2006 | EP1614415A1 Deprenyl compounds for treatment of glaucoma |
| 01/11/2006 | EP1614412A1 Process for the manufacture of free-flowing, powdery atorvastatin adsorbates |
| 01/11/2006 | EP1614357A1 Dietary supplements comprising prebiotics and fatty acid |
| 01/11/2006 | EP1613775A2 Selected rna motifs to include cell death and/or apoptosis |
| 01/11/2006 | EP1613740A1 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 01/11/2006 | EP1613736A2 Inhibition of viral pathogenesis |
| 01/11/2006 | EP1613679A1 Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions |
| 01/11/2006 | EP1613663A1 Cross-linked polysaccharide composition |
| 01/11/2006 | EP1613641A2 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 01/11/2006 | EP1613639A1 Avermectins substituted in the 4'' and 4´-positions having pesticidal properties |
| 01/11/2006 | EP1613634A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 01/11/2006 | EP1613632A1 Pyrrolo(1,2-b)pyridazine compounds and their use as crf-1 receptor antagonists |